Skystar Bio-Pharmaceutical CO (SKBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,596 | -1,957 | 1,175 | 1,460 | -270 |
| Depreciation Amortization | 1,467 | 5,554 | 1,322 | 110 | 0 |
| Accounts receivable | -1,068 | -1,405 | 179 | N/A | N/A |
| Accounts payable and accrued liabilities | 405 | 49 | 60 | N/A | N/A |
| Other Working Capital | -3,959 | -3,921 | -839 | 1,700 | 250 |
| Other Operating Activity | 1,259 | 2,625 | -296 | 20 | 21 |
| Operating Cash Flow | $3,700 | $943 | $1,601 | $3,290 | $1 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 58 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,616 | -403 | -2,099 | -6,590 | 0 |
| Purchase Of Investment | 316 | N/A | 265 | N/A | N/A |
| Sale Of Investment | -3,834 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -658 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,830 | 0 | 1,430 | 0 |
| Investing Cash Flow | $-5,076 | $-2,233 | $-1,834 | $-5,160 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 735 | 28 | 594 | N/A | N/A |
| Debt Issued | N/A | 4,908 | N/A | N/A | N/A |
| Debt Repayment | N/A | -880 | N/A | N/A | N/A |
| Other Financing Activity | 401 | -2,216 | -209 | 1,800 | 0 |
| Financing Cash Flow | $1,136 | $1,839 | $385 | $1,800 | $0 |
| Exchange Rate Effect | 45 | 30 | 1 | 50 | 0 |
| Beginning Cash Position | 772 | 192 | 39 | 40 | 0 |
| End Cash Position | 576 | 772 | 192 | 30 | 1 |
| Net Cash Flow | $-195 | $580 | $154 | $-10 | $1 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,700 | 943 | 1,601 | 3,290 | 1 |
| Capital Expenditure | -1,616 | -403 | -2,099 | N/A | N/A |
| Free Cash Flow | 2,085 | 541 | -498 | 3,290 | 1 |